⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Bronstein, Gewirtz & Grossman, LLC Is Investigating Alvotech (ALVO) And Encourages Stockholders to Connect
accessnewswire.com
ALVO
ATTENTION ALVO Investors: Securities Fraud Investigation Underway – Contact Levi & Korsinsky
accessnewswire.com
ALVO
Shareholders Alert: Investigation Into Alvotech (ALVO) - Contact Levi & Korsinsky to Protect Your Rights
accessnewswire.com
ALVO
Alvotech (ALVO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ALVO
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
globenewswire.com
ALVO
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
globenewswire.com
ALVO
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Alvotech (ALVO) and Encourages Stockholders to Learn More About the Investigation
accessnewswire.com
ALVO
Investigation Alert: Alvotech (ALVO) Under Scrutiny - Contact Levi & Korsinsky For Details
accessnewswire.com
ALVO
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
globenewswire.com
ALVO
Alvotech kynnir afkomu fyrstu níu mánaða ársins og ræðir nýjustu áfanga í rekstri félagsins þann 13. nóvember nk.
globenewswire.com
ALVO